参麦注射液治疗冠心病合并缓慢型心律失常的临床研究  

THE THERAPEUTIC EFFECTS OF SHENMAI ON BRADYCARDIA ARRHYTHIMA IN PATIENTS WITH CORONARY HEART DISEASE.

作　　者：马文霞 刘树文[2] 刘亚玲[2] 李晓琴[2] 马前峰[2] 马娜[2] 

机构地区：[1]陕西医学高等专科学校,710068 [2]西安市中心医院血管内科,710003

出　　处：《现代预防医学》2005年第7期841-842,共2页Modern Preventive Medicine

摘　　要：目的:观察参麦注射液对冠状动脉粥样硬化性心脏病合并缓慢型心律失常的治疗作用.方法:治疗组118例,常规用抗凝药、硝酸酯类等药外,另加用参麦注射液40ml加入5%葡萄糖液250ml静滴,1次/日,疗程15 d,有急性心肌梗死者,开始1～3 d,参麦24h维持,病情稳定后用法同前.对照组112例,常规用抗凝、硝酸酯类等药治疗.结果:治疗后心率提高,症状明显改善,治疗组、对照组总有效率分别为83.56%、52.25%.治疗组明显优于对照组(P＜0.05),结论:参麦注射液对冠状动脉粥样硬化心脏病合并缓慢型心律失常有良好的治疗作用.Objective:To observe therapeutic effect of Shenmai on bradycardia arrhythima in patients with coronary heart disease.Methods:The treatment group's patients were 118,with shenmai injection 40 ml+5%G.S 250 ml IV drip,patients with cardiac infarcation from first day to third day(24 h continuous use);Control groups:patients was 112 with frequent treatment(nitriteasprit).Result:The effective rate was 83.56% in the treatment group,51.25% in the control group,there were significantly different between them(P<0.05).Conclusion:It suggests that Shenmai can significantly treat bradycardia arrhythima patients with coronary heart disease.

关 键 词：参麦 冠心病 缓慢型心律失常 

分 类 号：R541.4[医药卫生—心血管疾病]